Phase II Study of Pyrotinib in Combination With Fulvestrant in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Hormone Receptor HR -Positive Metastatic Breast Cancer
Latest Information Update: 06 Dec 2022
At a glance
- Drugs Fulvestrant (Primary) ; Pyrotinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
Most Recent Events
- 29 Jul 2019 New trial record